Annovis Bio

ANVS • NYSE • Stock Fundamentals

Annovis Bio is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Maria L. Maccecchini, with a market cap of $87.6M.

Market Cap$87.6M

Employees6.0

CEOMaria L. Maccecchini

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026

Next EarningsAug 18, 2026 · in 3 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Annovis Bio

Annovis Bio (ANVS) has a market capitalization of $87.6M and trades on NYSE.

Annovis Bio has approximately 6 employees.